Technical Analysis for SAGE - Sage Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 169.3 0.11% 0.19
SAGE closed up 0.11 percent on Friday, August 23, 2019, on 1.49 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical SAGE trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Doji - Bearish? Reversal 0.00%
Multiple of Ten Bearish Other 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.11%

Older signals for SAGE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat rare central nervous system disorders. The company's lead product candidate includes SAGE-547, an intravenous (IV) agent that is in Phase I/II clinical development as an adjunctive therapy for the treatment of super-refractory status epilepticus (SRSE). Its products in IND-enabling toxicology and safety pharmacology testing comprise SAGE-689, an adjunctive second-line therapy for the treatment of status epilepticus (SE); and SAGE-217, an IV monotherapy for the treatment of refractory status epilepticus, as well as an orally delivered maintenance therapeutic to prevent recurrent seizures in patients whose SE, RSE, or SRSE has resolved. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was founded in 2010 and is based in Cambridge, Massachusetts.
Chemistry Biopharmaceutical Physical Sciences Drugs Antidepressants Gabaa Receptor Positive Allosteric Modulators Adjunctive Therapy Anticonvulsants Neurosteroids
Is SAGE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 193.56
52 Week Low 79.88
Average Volume 353,430
200-Day Moving Average 151.2618
50-Day Moving Average 173.8856
20-Day Moving Average 164.437
10-Day Moving Average 165.166
Average True Range 5.5135
ADX 13.5
+DI 26.1223
-DI 19.8185
Chandelier Exit (Long, 3 ATRs ) 158.5995
Chandelier Exit (Short, 3 ATRs ) 170.5405
Upper Bollinger Band 172.0903
Lower Bollinger Band 156.7837
Percent B (%b) 0.82
BandWidth 9.308489
MACD Line -1.6461
MACD Signal Line -2.7207
MACD Histogram 1.0746
Fundamentals Value
Market Cap 6.33 Billion
Num Shares 37.4 Million
EPS -6.09
Price-to-Earnings (P/E) Ratio -27.80
Price-to-Sales 0.00
Price-to-Book 8.73
PEG Ratio 0.72
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 178.35
Resistance 3 (R3) 178.83 176.29 176.84
Resistance 2 (R2) 176.29 173.99 176.05 176.34
Resistance 1 (R1) 172.80 172.56 171.53 172.32 175.84
Pivot Point 170.26 170.26 169.62 170.02 170.26
Support 1 (S1) 166.76 167.95 165.49 166.28 162.76
Support 2 (S2) 164.22 166.53 163.98 162.26
Support 3 (S3) 160.73 164.22 161.76
Support 4 (S4) 160.25